Ex Parte Ushioda et al - Page 6




          Appeal No. 2004-0770                                                        
          Application No. 09/795,310                                                  


          inherency, every limitation of the claim.  See In re King, 801 F.2d         
          1324, 1326, 231 USPQ 136, 138 (Fed. Cir. 1986).  Implicit in our            
          review of the examiner’s anticipation analysis is that the claim            
          must first have been correctly construed to define the scope and            
          meaning of each contested limitation.  See Gechter v. Davidson, 116         
          F.3d 1454, 1457, 43 USPQ2d 1030, 1032 (Fed. Cir. 1997).                     
               The examiner has construed claim 1 on appeal as open to                
          include other components such as isotactic polypropylene, as long           
          as the recited components are present in the required percentages           
          (Answer, pages 5-6).  Appellants contest this claim construction            
          and argue that the claims are limited by the phrase “totaling 100%          
          by weight” as recited at the end of claim 1 on appeal.  Appellants          
          would construe claim 1 on appeal as including only two components           
          which make up 100% of the total polymers (Brief, pages 5 and 6;             
          Reply Brief, page 5), and argue that claim 1 does not include               
          isotactic polypropylene (Brief, page 7; Reply Brief, page 6).               
               It is undisputed that claim 1 on appeal recites the                    
          transitional term “comprising” (Answer, page 5; Reply Brief, page           
          5).  It is well settled that the transitional term “comprising”             
          used in claim language is a “term of art ... which means that the           
          named elements are essential, but other elements may be added and           
          still form a construct within the scope of the claims.”  Genentech          
                                          6                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007